PAIN TRIGGERS
Inability to consistently fill Adderall or Vyvanse prescriptions anywhere in the city.
SaaS· ADHD patientsPain 8.00/10WTP 7.0/10Market 6.0/10Validation 8.0Confidence 90%Jun 26, 2026
PharmaTrack NYC: Crowd-Sourced Real-Time ADHD Medication Availability Mapping
Patients with ADHD in NYC cannot consistently locate pharmacies with Adderall or Vyvanse in stock due to ongoing medication shortages, leading to severe disruptions in their daily life and employment efforts, while current lookup services require high upfront fees.
crowdsourcinghealthcarelocation-basednycproductivitysaas
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Patients with ADHD in NYC cannot consistently find local pharmacies with Adderall or Vyvanse in stock due to ongoing medication shortages, leading to severe disruptions in their daily life and employment efforts.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Brooklyn/NYC please help
ADHD34
Brooklyn/NYC please help
ADHD34
MedFinder is said to almost guarantee to find them in stock within the city for a $50 fee
commentI am so sorry, it sucks, I can relate. MedFinder is said to almost guarantee to find them in stock within the city for a $50 fee, if you haven’t tried that yet
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patientsN Y C A D H D Patients & Job Seekers
Individuals in NYC requiring consistent ADHD stimulant medication who are facing employment disruptions due to severe local supply shortages.
Context
Consistently fill ADHD stimulant prescriptions (Adderall or Vyvanse) within New York City to manage symptoms and focus on job applications.
Traveling long distances to outer boroughs where stock might be available.
Paying a $50 premium fee to third-party tracking services to locate stock.
Current Workarounds
Traveling hours to remote outer boroughs like the Bronx based on random word-of-mouth tips
Paying $50 one-off fees to manual third-party search services like MedFinder
Calling dozens of local pharmacies daily only to be turned away due to strict control policies
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard local pharmacies in Brooklyn/NYC consistently lack stock of critical ADHD medications.
Paid search services like MedFinder require a $50 fee, which is a barrier for unemployed users.
OPPORTUNITY & VALUE
Why Now
High volume of users explicitly calling out the absolute vacancy of inventory across standard Brooklyn/Manhattan storefronts combined with the heavy financial toll of single-use automated broker platforms.
Value Proposition
Community-driven, hyper-local crowd-sourcing that provides instant visibility across the 5 boroughs without forcing vulnerable or unemployed users to pay a $50 per-search penalty.
Product Direction
A location-based, crowd-sourced availability tracker tailored for NYC residents, leveraging anonymous user-reported stock verifications and aggregated pharmacist data to show heatmaps of verified medication fills.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9/moFree map access for contributors · Premium alerts for non-contributors
Model
Freemium SaaS subscription
WILLINGNESS TO PAY
Users are already paying up to $50 per lookup to competitors like MedFinder out of desperation; a lower-priced, immediate subscription or pass offers a significantly cheaper alternative during job hunt periods.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Find your ADHD medication in stock nearby without the $50 finder fee.”
A location-based, crowd-sourced availability tracker tailored for NYC residents, leveraging anonymous user-reported stock verifications and aggregated pharmacist data to show heatmaps of verified medication fills.
Core Features
Interactive NYC map showing recent user-verified successful fills of Adderall and Vyvanse
Anonymous 'Success Report' submission workflow for community-driven tracking
Stock freshness indicators (e.g., 'Verified 2 hours ago' vs '3 days ago')
Filter by specific borough, dosage (mg), and manufacturer type (generic vs brand)
Weekly Roadmap
1
W1-W2
Core mapping platform and crowd-sourced submission forms are active.
- •Deploy Mapbox/Leaflet UI pinned to New York City coordinates
- •Build anonymous 'I filled my prescription here' log form with dosage/date details
- •Set up database architecture to automatically expire logs older than 72 hours
2
W3-W4
Verification system and basic user accounts launch to track trust tiers.
- •Implement upvote/downvote confirmation buttons for other local users on active pharmacy pins
- •Integrate user location verification to confirm they are physically near the pharmacy when reporting
- •Create notification preferences for specific medication types
3
W5
SMS/Twilio premium tier notification integration and beta testing.
- •Build Stripe checkout workflow for premium instant-alert tier
- •Configure Twilio automated text alerts triggered when a pharmacy within a chosen zip code is flagged green
- •Seed initial 100 entries via manual check-ins and curated local forum data
4
W6
Public launch targeting NYC digital communities.
- •Launch platform link in NYC and ADHD specific subreddits and X communities
- •Provide free premium access codes to early active crowd-source contributors to bootstrap network effects
- •Monitor fill success feedback loops and clean up obsolete pharmacy entries
Launch Strategy
Launch directly inside localized NYC subreddits (r/nyc, r/Brooklyn, r/Astoria) and neurodivergent community hubs where shortage megathreads are already highly active.
RISKS & ASSUMPTIONS
Top Risks
Stale Data and User Frustration
If a user travels to a pharmacy reported as 'in stock' only to find it sold out, trust in the platform drops instantly.
Legal and DEA Regulatory Scraping Risks
Tracking controlled substances publicly may draw scrutiny from pharmacy compliance teams or law enforcement regarding pharmacy safety.
Crowdsourcing Inaccuracy
Bad actors or confused users submitting wrong dosages or incorrect pharmacy locations, polluting map validity.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "crowdsourcing", "healthcare", "location-based", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "PharmaTrack NYC: Crowd-Sourced Real-Time ADHD Medication Availability Mapping" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for crowdsourcing?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.